Literature DB >> 8671815

Renal function on and off lithium in patients treated with lithium for 15 years or more. A controlled, prospective lithium-withdrawal study.

H Bendz1, I Sjödin, M Aurell.   

Abstract

BACKGROUND: Controversy remains over the magnitude and reversibility of reduced renal function in long-term lithium patients.
METHODS: Thirteen patients with 18 years (range 15-24) on lithium discontinued the treatment, and were re-examined twice after 5 and 9 weeks (4-16) off lithium. They were compared to a non-lithium psychiatric control group, matched for age and sex.
RESULTS: Glomerular filtration rate (GFR) tended to improve from 69 (39-96) to 74 (39-94) ml/min/1.73 m2 BSA, P = 0.057, which was not significantly different from 78 (61-106 ml/min per 1.73 m2 BSA in the controls. Reduced GFR was found in only two of the lithium patients off lithium, and in none of the controls. Maximal urinary concentrating capacity did not improve at all. It was 637 (130-875) mOsm/kg H2O in the lithium patients, which was lower than 856 (705-1.035) mOsm/kg H2O (P < 0.01) in the controls. Two of the lithium patients had isosthenuria.
CONCLUSIONS: Lithium patients often have an irreversible, clinically important reduction of Umax, sometimes progressing to nephrogenic diabetes insipidus, while GFR is well preserved in most patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8671815

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

Review 1.  Lithium and the kidney: an updated review.

Authors:  M Gitlin
Journal:  Drug Saf       Date:  1999-03       Impact factor: 5.606

Review 2.  Chronic kidney disease in lithium-treated older adults: a review of epidemiology, mechanisms, and implications for the treatment of late-life mood disorders.

Authors:  Soham Rej; Dominique Elie; Istvan Mucsi; Karl J Looper; Marilyn Segal
Journal:  Drugs Aging       Date:  2015-01       Impact factor: 3.923

Review 3.  Glycogen synthase kinase-3 regulation of urinary concentrating ability.

Authors:  Reena Rao
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-09       Impact factor: 2.894

4.  GSK3beta mediates renal response to vasopressin by modulating adenylate cyclase activity.

Authors:  Reena Rao; Satish Patel; Chuanming Hao; James Woodgett; Raymond Harris
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

5.  The effect of serum lithium levels on renal function in geriatric outpatients: a retrospective longitudinal study.

Authors:  Soham Rej; Karl Looper; Marilyn Segal
Journal:  Drugs Aging       Date:  2013-06       Impact factor: 3.923

Review 6.  Lithium nephrotoxicity revisited.

Authors:  Jean-Pierre Grünfeld; Bernard C Rossier
Journal:  Nat Rev Nephrol       Date:  2009-05       Impact factor: 28.314

Review 7.  A decision analysis of long-term lithium treatment and the risk of renal failure.

Authors:  U Werneke; M Ott; E Salander Renberg; D Taylor; B Stegmayr
Journal:  Acta Psychiatr Scand       Date:  2012-03-09       Impact factor: 6.392

8.  Renal failure in lithium-treated bipolar disorder: a retrospective cohort study.

Authors:  Helen Close; Joe Reilly; James M Mason; Mukesh Kripalani; Douglas Wilson; John Main; A Pali S Hungin
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

9.  Lower estimated glomerular filtration rates in patients on long term lithium: a comparative study and a meta-analysis of literature.

Authors:  Chaturaka Rodrigo; Nipun Lakshitha de Silva; Ravindi Gunaratne; Senaka Rajapakse; Varuni Asanka De Silva; Raveen Hanwella
Journal:  BMC Psychiatry       Date:  2014-01-08       Impact factor: 3.630

10.  Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters.

Authors:  Leonardo Tondo; Maria Abramowicz; Martin Alda; Michael Bauer; Alberto Bocchetta; Lorenza Bolzani; Cynthia V Calkin; Caterina Chillotti; Diego Hidalgo-Mazzei; Mirko Manchia; Bruno Müller-Oerlinghausen; Andrea Murru; Giulio Perugi; Marco Pinna; Giuseppe Quaranta; Daniela Reginaldi; Andreas Reif; Philipp Ritter; Janusz K Rybakowski; David Saiger; Gabriele Sani; Valerio Selle; Thomas Stamm; Gustavo H Vázquez; Julia Veeh; Eduard Vieta; Ross J Baldessarini
Journal:  Int J Bipolar Disord       Date:  2017-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.